why choose us

First received: September 12, 2023

Clinical Trial: A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Palmoplantar Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Non-Pustular PalmoPlantar and Genital Psoriasis (

Brief Summary: The purpose of this study is to measure the safety and effectiveness of deucravatinib in participants with non-pustular palmoplantar psoriasis and genital psoriasis.

Read more